An immunoradiometric assay for thymosin alpha 1

Area of Science:

• Immunology
• Biochemistry
• Assay Development

Background:

• Thymosin alpha 1 is a peptide hormone with immunomodulatory functions.
• Accurate quantification of thymosin alpha 1 is crucial for understanding its biological roles.
• Existing methods for thymosin alpha 1 measurement may have limitations in sensitivity or specificity.

Purpose of the Study:

• To develop and validate a sensitive and specific immunoradiometric assay for thymosin alpha 1(1-28).
• To establish the assay's performance characteristics, including detection limit and specificity.
• To investigate the levels of thymosin alpha 1 in human plasma across different age groups.

Main Methods:

• Development of a two-site immunoradiometric assay using a monoclonal antibody (mAb) and a polyclonal antiserum (pAb).
• Immobilization of a mAb specific for the N-terminal sequence (acetylated ser1) 1-5 of thymosin alpha 1 on solid phase beads.
• Utilizing a pAb specific for the C-terminal sequence 16-28 and a 125I-labelled anti-rabbit IgG goat antibody for detection.

Main Results:

• The assay demonstrated a minimal detection limit of approximately 1.9 pg/ml.
• Plasma levels of thymosin alpha 1 were found to be approximately fivefold higher in healthy subjects aged 0-3 years compared to older individuals.
• High-Performance Liquid Chromatography (HPLC) analysis confirmed a single immunoreactive form of thymosin alpha 1 in healthy subjects' plasma, matching synthetic thymosin alpha 1.

Conclusions:

• The developed immunoradiometric assay provides a sensitive and specific method for quantifying thymosin alpha 1(1-28).
• The assay is suitable for measuring thymosin alpha 1 in biological fluids and tissues.
• Age-related differences in plasma thymosin alpha 1 levels were observed, suggesting potential developmental roles.